16 August 2018
Visiongain’s new report Pharma Distribution Market Forecasts 2017-2027: Branded and Generic Drug Distribution, Leading National Markets, Leading Wholesalers, US, Europe, Japan and China indicates that the pharma wholesale and distribution market will see $1,195bn in spending in 2021.
The pharma wholesale and distribution market is estimated at $893.69bn in 2016 and is expected to grow at a CAGR of 6.0% in the first half of the forecast period. The market is expected to grow at a CAGR of 5.2% from 2017-2027. In 2016, the branded drugs submarket held 79.5% share of the pharma wholesale and distribution market.
The lead analyst of this report said “The pharmaceutical wholesale and distribution market will be driven by an overall increased demand for pharmaceuticals. This is a result of the growing ageing population in developed countries and the increasing access to healthcare of the expanding middle class in the emerging economies.
Market expansion will be partially offset by reduced revenue generation of branded products as patents expire and cheaper generic version become available. Additionally, specialty products will continue to generate revenue, even after their patent protection is lost owing to the complexity of copying these products.”
The 265-page report contains 83 tables and 97 figures that add visual analysis in order to explain the developing trends within the pharma wholesale and distribution market.
Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the pharma wholesale and distribution market and its leading submarkets: Branded Drugs, Generic Drugs, Other Medicines.
The 265-page report offers market forecasts for the leading national markets: US, Germany, France, The UK, Italy, Spain, Japan, China, Brazil, Russia and India
Moreover, our work discusses the leading companies in the pharma wholesale and distribution market. Our study also includes SWOT and STEP analysis of this industry and market.
The report Pharma Wholesale and Distribution Market Forecasts 2017-2027: Branded and Generic Drug Distribution, Leading National Markets, Leading Wholesalers, US, Europe, Japan and China report will be of value to anyone who wants to better understand the pharma wholesale and distribution market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the pharma wholesale and distribution market.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.
26 January 2022
Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.
26 January 2022
The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.
24 January 2022
The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.